Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Moderate Symptomatic COVID-19
NCT04527562Completed
- Sponsor
- Dhaka Medical College
- Start
- Jul 2020
- Primary completion
- Nov 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of colchicine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Dhaka Medical College. Primary endpoint: Time to develop clinical deterioration at 14 days. Started Jul 2020; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04527562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04527562.